Cyclodextrin/imatinib complexation: binding mode and charge dependent stabilities.

No abstract is available for this paper.

• Publication year

  2007

• Venue

  European Journal of Pharmaceutical Sciences

• Publication date

  2007-02-01

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1016/J.EJPS.2006.10.008PMID 17145172
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Complexation of enalapril maleate with beta-cyclodextrin: NMR spectroscopic study in solution

  2006cited by this paper
• Fragmentation study of imatinib and characterization of new imatinib metabolites by liquid chromatography-triple-quadrupole and linear ion trap mass spectrometers.

  2006cited by this paper
• Inclusion complexation of novocaine by beta-cyclodextrin in aqueous solutions.

  2006cited by this paper
• Structure elucidation of the tetrahydrocannabinol complex with randomly methylated beta-cyclodextrin.

  2006cited by this paper
• Characterization of host-guest complexes of cucurbit[n]uril (n = 6, 7) by electrospray ionization mass spectrometry.

  2006cited by this paper
• Sildenafil/cyclodextrin complexation: stability constants, thermodynamics, and guest-host interactions probed by 1H NMR and molecular modeling studies.

  2006cited by this paper
• Inclusion complexation of novocaine by β-cyclodextrin in aqueous solutions

  2006cited by this paper
• Solubilization of poorly soluble lichen metabolites for biological testing on cell lines.

  2005cited by this paper
• The effect of cyclodextrins on the aqueous solubility of a new MMP inhibitor: phase solubility, 1 H-NMR spectroscopy and molecular modeling studies, preparation and stability study of nebulizable solutions.

  2005cited by this paper
• Uncommon Interactions of Aliphatic Dicarboxylic Acids with Cyclodextrins

  2005cited by this paper
• Acid-base profiling of imatinib (gleevec) and its fragments.

  2005cited by this paper
• Multicomponent complex formation between vinpocetine, cyclodextrins, tartaric acid and water-soluble polymers monitored by NMR and solubility studies.

  2005cited by this paper
• Evaluation of cyclodextrin solubilization of drugs.

  2005cited by this paper
• Clinical Pharmacokinetics of Imatinib

  2005cited by this paper
• NMR studies of the inclusion complex between beta-cyclodextrin and paroxetine.

  2004cited by this paper
• NMR studies of the inclusion complex between β-cyclodextrin and paroxetine

  2004cited by this paper
• Design and evaluation of cyclodextrin-based drug formulation.

  2004cited by this paper
• Multimodal molecular encapsulation of nicardipine hydrochloride by beta-cyclodextrin, hydroxypropyl-beta-cyclodextrin and triacetyl-beta-cyclodextrin in solution. Structural studies by 1H NMR and ROESY experiments.

  2003cited by this paper
• Efficient determination and evaluation of model cyclodextrin complex binding constants by electrospray mass spectrometry

  2003cited by this paper
• Supramolecular Complex Formation: A Study of the Interactions between β‐Cyclodextrin and Some Different Classes of Organic Compounds by ESI‐MS, Surface Tension Measurements, and UV/Vis and 1H NMR Spectroscopy

  2003cited by this paper
• Multimodal molecular encapsulation of nicardipine hydrochloride by β-cyclodextrin, hydroxypropyl-β-cyclodextrin and triacetyl-β-cyclodextrin in solution. Structural studies by 1H NMR and ROESY experiments

  2003cited by this paper
• Quantitative approach for the screening of cyclodextrins by nuclear magnetic resonance spectroscopy in support of chiral separations in liquid chromatography and capillary electrophoresis enantioseparation of norgestrel with alpha-, beta- and gamma-cyclodextrins.

  2002cited by this paper
• Structural mechanism for STI-571 inhibition of abelson tyrosine kinase.

  2000cited by this paper
• Beta-cyclodextrin/epoxysuccinyl peptide conjugates: a new drug targeting system for tumor cells.

  2000cited by this paper
• Determination of Association Constants (Ka) from Solution NMR Data

  2000cited by this paper
• Introduction and General Overview of Cyclodextrin Chemistry.

  1998cited by this paper
• NMR Studies of Cyclodextrins and Cyclodextrin Complexes.

  1998cited by this paper
• The Stability of Cyclodextrin Complexes in Solution.

  1997cited by this paper
• Electrospray Ionization Mass Spectrometry in Supramolecular Chemistry: Characterization of Non‐covalent Cyclodextrin Complexes

  1996cited by this paper
• False positives and the detection of cyclodextrin inclusion complexes by electrospray mass spectrometry

  1995cited by this paper
• Cyclodextrins and their inclusion complexes

  1982cited by this paper
• A study of some problems in determining the stoicheiometric proton dissociation constants of complexes by potentiometric titrations using a glass electrode

  1967cited by this paper
• Phase solubility techniques

  1965cited by this paper

• Physicochemical characterization, cyclodextrin complexation, and protonation state-dependent receptor binding of selected tyrosine kinase inhibitors

  2026cites this paper
• Synthesis of supramolecular nanoparticles for docetaxel using sulfobutyl ether cyclodextrin with improved therapeutic efficacy in breast cancer

  2026cites this paper
• Cyclodextrin-Based Niosomal Delivery of Imatinib against A549 Nonsmall Cell Lung Cancer Cells

  2025cites this paper
• Cyclodextrins and their applications in pharmaceutical and related fields.

  2025cites this paper
• Electrostatically driven supramolecular drug-carrier system for targeted, efficient, safer Cancer chemotherapy.

  2025cites this paper
• Fabrication of biocompatible water-soluble supramolecular nanofibers of oseltamivir with methyl-β-cyclodextrin for enhanced drug release

  2024cites this paper
• Effect of substituted cyclodextrins on ibrutinib solubility and characterization of IBR-cyclodextrin inclusion complexes by isothermal titration calorimetry in solution state

  2024cites this paper
• Cyclodextrin Drugs in Liposomes: Preparation and Application of Anticancer Drug Carriers

  2024cites this paper
• Enhancing ketoprofen's solubility and anti-inflammatory efficacy with safe methyl-β-cyclodextrin complexation

  2024cites this paper
• Synergistic applications of cyclodextrin-based systems and metal-organic frameworks in transdermal drug delivery for skin cancer therapy.

  2024cites this paper
• The small-molecule kinase inhibitor ceritinib, unlike imatinib, causes a significant disturbance of lipid membrane integrity: A combined experimental and MD study.

  2023cites this paper
• Flipping hosts in hyperfine fields of paramagnetic guests

  2023cites this paper
• CO2-Responsive drug delivery system created by supramolecular design and assembly for safer, more effective cancer therapy

  2023cites this paper
• β-cyclodextrin complex formation and protonation equilibria of morphine and other opioid compounds of therapeutic interest.

  2022cites this paper
• Biodegradable and biocompatible polymeric nanoparticles for enhanced solubility and safe oral delivery of docetaxel: in vivo toxicity evaluation.

  2021cites this paper
• Cyclodextrins: Structural, Chemical, and Physical Properties, and Applications

  2021cites this paper
• A selective p53 activator and anticancer agent to improve colorectal cancer therapy.

  2021cites this paper
• β‐Cyclodextrin Encapsulation of Synthetic AHLs: Drug Delivery Implications and Quorum‐Quenching Exploits

  2020cites this paper
• Study of the binding affinity between imatinib and α-1 glycoprotein using nuclear spin relaxation and isothermal titration calorimetry.

  2020cites this paper
• Comparative analysis of the full set of methylated β‐cyclodextrins as chiral selectors in capillary electrophoresis

  2019cites this paper
• Renal Clearable Theranostic Nanoplatforms for Gastrointestinal Stromal Tumors

  2019cites this paper
• Equilibrium, structural and antibacterial characterization of moxifloxacin-β-cyclodextrin complex

  2018cites this paper
• Cyclodextrins: structure, physicochemical properties and pharmaceutical applications.

  2018cites this paper
• Solubility: a speed–breaker on the drug discovery highway

  2017cites this paper
• Cyclodextrin as a Drug Carrier Increasing Drug Solubility

  2017cites this paper
• Physicochemical Characterization and Cyclodextrin Complexation of the Anticancer Drug Lapatinib

  2017cites this paper
• Using Dental Stem Cells to Regenerate Tooth Tissue and Whole Tooth Replacement

  2017cites this paper
• Cyclodextrin complexation improves aqueous solubility of the antiepileptic drug, rufinamide: solution and solid state characterization of compound-cyclodextrin binary systems

  2017cites this paper
• Analytical techniques for characterizing cyclodextrins and their inclusion complexes with large and small molecular weight guest molecules

  2017cites this paper
• pH-Sensitive Supramolecular Assemblies of β-Cyclodextrin and 2-Aminodiphenylamine in Water Medium: Structure, Solubility and Stability

  2016cites this paper
• Chiral separation of asenapine enantiomers by capillary electrophoresis and characterization of cyclodextrin complexes by NMR spectroscopy, mass spectrometry and molecular modeling.

  2016cites this paper
• Emerging understanding of the protein corona at the nano-bio interfaces

  2016cites this paper
• Renal Clearable Organic Nanocarriers for Bioimaging and Drug Delivery

  2016cites this paper
• Polymer hydrogels based on cyclodextrins as carriers for drugs: synthesis and physicochemical properties

  2015cites this paper
• Impact of Extracellular Matrix on Cellular Behavior: A Source of Molecular Targets in Disease

  2015cites this paper
• A Comprehensive Review on Cyclodextrin-Based Carriers for Delivery of Chemotherapeutic Cytotoxic Anticancer Drugs

  2015cites this paper
• Insoluble drug delivery strategies: review of recent advances and business prospects

  2015influential citation
• Thermodynamic study of inclusion complexes of zaleplon with natural and modified cyclodextrins

  2014cites this paper
• Analytical techniques for characterization of cyclodextrin complexes in aqueous solution: a review.

  2014cites this paper
• Theoretical Background and Literature Overview

  2014cites this paper
• Oblikovanje i vrednovanje ciklodekstrinskih terapijskih sustava za oralnu primjenu zaleplona

  2014cites this paper
• Delivering drug‑polymer complex via quick dissolving film : A step towards the development of an appropriate pediatric formulation

  2013cites this paper
• The novel oral imatinib microemulsions: physical properties, cytotoxicity activities and improved Caco-2 cell permeability

  2013cites this paper
• Isothermal titration calorimetry (ITC) study of natural cyclodextrins inclusion complexes with drugs

  2013cites this paper
• CYCLODEXTRINS IN PHARMACEUTICS, COSMETICS, AND BIOMEDICINE

  2013cites this paper
• Recent researches in triazole compounds as medicinal drugs.

  2012cites this paper
• A LITERATURE REVIEW OF CYCLODEXTRINS INCLUSION COMPLEXES CHARACTERIZATION - PART I: PHASE SOLUBILITY DIAGRAM, DISSOLUTION AND SCANNING ELECTRON MICROSCOPY

  2012cites this paper
• β-Cyclodextrin duplexes that are connected through two disulfide bonds: potent hosts for the complexation of organic molecules.

  2012cites this paper
• Chemically bonded cationic β-cyclodextrin derivatives and their applications in supercritical fluid chromatography.

  2012cites this paper
• 1 CYCLODEXTRINS AND THEIR INCLUSION COMPLEXES

  2011cites this paper
• Cyclodextrins and Their Inclusion Complexes

  2011cites this paper
• Molecular recognition and enhancement of aqueous solubility and bioactivity of CD437 by β-cyclodextrin.

  2011cites this paper
• Poisson-Boltzmann continuum-solvation models: applications to pH-dependent properties of biomolecules.

  2011cites this paper
• Physico-chemical characterization and in vitro/in vivo evaluation of loratadine:dimethyl-β-cyclodextrin inclusion complexes.

  2011cites this paper
• Synthesis and characterization of the inclusion complex between repaglinide and sulfobutylether-β-cyclodextrin (Captisol®)

  2011cites this paper
• Preparation and Physicochemical Characterization of Amoxicillin β-cyclodextrin Complexes

  2010cites this paper
• Preparation and characterization of hydroxypropyl-β-cyclodextrin inclusion complex of eugenol: differential pulse voltammetry and (1)H-NMR.

  2010cites this paper
• Drug Complexation and Formulation of a Buccal Tablet

  2010cites this paper
• Formulation and In Vitro-In Vivo Evaluation of Black Raspberry Extract-Loaded PLGA/PLA Injectable Millicylindrical Implants for Sustained Delivery of Chemopreventive Anthocyanins

  2010cites this paper
• High-throughput phase-distribution method to determine drug-cyclodextrin binding constants.

  2009cites this paper
• Review on supermolecules as chemical drugs

  2009cites this paper
• Characterization of aspartame-cyclodextrin complexation.

  2009cites this paper
• Electrospray-ionization mass spectrometry study of cyclodextrin complexes with A007 prodrugs.

  2009cites this paper
• Utility of cyclodextrins in the formulation of genistein part 1. Preparation and physicochemical properties of genistein complexes with native cyclodextrins.

  2008cites this paper
• Formes amorphes stabilisées du mésylate d'imatinib

  2008cites this paper
• Determination of binding constants by affinity capillary electrophoresis, electrospray ionization mass spectrometry and phase-distribution methods.

  2008cites this paper
• Equilibrium and structural characterization of imatinib protonation, cyclodextrin complex formation and liposome encapsulation

  2007cites this paper
• Solubility of sparingly-soluble ionizable drugs.

  2007cites this paper
• Stabilisierte amorphe Formen von Imatinib Mesylat

  2007cites this paper
• Cyclodextrins as pharmaceutical solubilizers.

  2007influential citation